Back
Bellevue Life Sciences Acquisition Vs. Slam Industry Stock Comparison
Sell
32
BLAC
Bellevue Life Sciences Acquisition
Last Price:
10.91
Seasonality Move:
0.77%
Sell
46
SLAMF
Slam
Last Price:
11.08
Seasonality Move:
0.89%
Sell
32
Bellevue Life Sciences Acquisition (BLAC)
is a Sell
Is Bellevue Life Sciences Acquisition a Buy, Sell or Hold?
- The current Bellevue Life Sciences Acquisition [BLAC] share price is $10.89. The Score for BLAC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BLAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Slam (SLAMF)
is a Sell
Is Slam a Buy, Sell or Hold?
- The current Slam [SLAMF] share price is $11.08. The Score for SLAMF is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- SLAMF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BLAC Stock Price Chart
What is Bellevue Life Sciences Acquisition's stock price today?
-
The Bellevue Life Sciences Acquisition share price today is $10.89
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLAC is experiencing slight buying pressure.
SLAMF Stock Price Chart
BLAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 61.32 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.8 - 10.88) | Buy |
| Bollinger Bands (100): | (10.74 - 10.86) | Buy |
SLAMF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 39.39 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.06 - 11.14) | Sell |
| Bollinger Bands (100): | (11.06 - 11.14) | Sell |
BLAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.88 | Buy |
| 20-day SMA: | 10.85 | Buy |
| 50-day SMA: | 10.84 | Buy |
| 200-day SMA: | 10.7 | Buy |
| 8-day EMA: | 10.88 | Buy |
| 20-day EMA: | 10.86 | Buy |
| 50-day EMA: | 10.84 | Buy |
| 200-day EMA: | 10.69 | Buy |
SLAMF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.08 | Sell |
| 20-day SMA: | 11.09 | Sell |
| 50-day SMA: | 11.12 | Sell |
| 200-day SMA: | 11.01 | Buy |
| 8-day EMA: | 11.08 | Sell |
| 20-day EMA: | 11.09 | Sell |
| 50-day EMA: | 11.1 | Sell |
| 200-day EMA: | 11 | Buy |
Bellevue Life Sciences Acquisition Earnings Growth & BLAC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Slam Earnings Growth & SLAMF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bellevue Life Sciences Acquisition Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Slam Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||